Effectiveness of ω-3 Supplementation on Biochemical, Clinical, and Inflammatory Parameters in Patients with Diabetes: A Systematic Review and Meta-analysis
Abstract
Omega-3 (n-3) polyunsaturated fatty acids, including marine-derived eicosapentaenoic acid and docosahexaenoic acid, as well as plant-derived formulations rich in α-linolenic acid, have been proposed as adjunctive therapy in diabetes because of their potential effects on lipid metabolism, inflammation, oxidative stress, and neuroprotection. Searches were performed in MEDLINE, EMBASE, SCOPUS, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, and Web of Science through January 2026. Outcomes included lipid parameters, glycemic markers, inflammatory and oxidative stress biomarkers, and corneal nerve branch density (CNBD). Random-effects models were applied. Eleven trials met the criteria for quantitative synthesis. Pooled analyses showed no significant effects on triglycerides, low-density or high-density lipoprotein cholesterol, glycated hemoglobin, fasting plasma glucose, or inflammatory and oxidative stress biomarkers, with substantial heterogeneity across several outcomes. In contrast, fasting insulin and homeostasis model assessment of insulin resistance were significantly reduced with low heterogeneity, and CNBD showed a consistent improvement with no detectable heterogeneity, suggesting potential benefits for insulin sensitivity and small-fiber nerve integrity. Overall, the certainty of evidence ranged from very low to low, mainly because of heterogeneity, imprecision, and small sample sizes. ω-3 supplementation…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.